BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1947758)

  • 21. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
    Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
    Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum leucine amino peptidase levels as a marker in testicular tumours.
    Khanolkar MM; Sirsat AV; Deshmane VH; Kamat MR
    Indian J Med Res; 1992 Dec; 96():372-5. PubMed ID: 1289250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum lactate dehydrogenase and human choriogonadotrophin in seminoma.
    Fosså A; Fosså SD
    Br J Urol; 1989 Apr; 63(4):408-15. PubMed ID: 2653557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ["Burned out" testicular tumor: a rare form of germ cell neoplasias].
    Casella R; Rochlitz C; Sauter G; Gasser TC
    Schweiz Med Wochenschr; 1999 Feb; 129(6):235-40. PubMed ID: 10093882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
    Lippert MC; Javadpour N
    Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-surgical treatment of testicular cancer: guidelines for the urologist].
    Páez Borda A; Llorente Abarca C; Herrero Payo A; Acebal Lucia J; Berenguer Sánchez A
    Actas Urol Esp; 1993 Apr; 17(4):226-33. PubMed ID: 8393610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of close testicular tumor after-care].
    Erpenbach K; Derschum W; Reis M; von Vietsch H
    Urologe A; 1990 Mar; 29(2):102-7; discussion 107-9. PubMed ID: 2158683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appropriateness of testicular cancer management: a population-based cohort study.
    Cheung WY; Demers A; Hossain D; Owen T; Ahmed S; Czaykowski PM
    Can J Urol; 2007 Jun; 14(3):3542-50. PubMed ID: 17594744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic progress in testicular carcinoma].
    Aiginger P; Kolbe H; Kühböck J; Spona J
    Acta Med Austriaca; 1978; 5(4-5):159-61. PubMed ID: 91300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of stage I germ cell tumors of the testis].
    Santomé Couto L; Tabernero Caturla JM; Villavicencio Mavrich H; Valentí Moreno V
    Arch Esp Urol; 2000; 53(6):474-86. PubMed ID: 11002515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of clinical stage I nonseminomatous germ-cell testis tumors.
    Flechon A; Droz JP
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):21-30. PubMed ID: 12597346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Histopathology of testicular germ cell tumors].
    Morinaga S; Sasano N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2460-7. PubMed ID: 6210048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of tumor markers in the treatment of germ cell tumor].
    Niwakawa M; Tobisu K
    Gan To Kagaku Ryoho; 2001 Aug; 28(8):1159-65. PubMed ID: 11525037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germ cell tumours of the testis.
    Gori S; Porrozzi S; Roila F; Gatta G; De Giorgi U; Marangolo M
    Crit Rev Oncol Hematol; 2005 Feb; 53(2):141-64. PubMed ID: 15661565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours.
    Venkitaraman R; Johnson B; Huddart RA; Parker CC; Horwich A; Dearnaley DP
    BJU Int; 2007 Jul; 100(1):30-2. PubMed ID: 17552950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer.
    Christensen TB; Engbaek F; Marqversen J; Nielsen SI; Kamby C; von der Maase H
    Br J Cancer; 1999 Jul; 80(10):1577-81. PubMed ID: 10408402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview.
    von Eyben FE
    Oncodev Biol Med; 1983; 4(6):395-414. PubMed ID: 6196755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of serum beta-chain human chorionic gonadotropin in the management of testis tumor.
    Walter MC
    Natl Cancer Inst Monogr; 1978 Dec; (49):219. PubMed ID: 748772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.